Radiation Oncology/RTOG Trials/0321

From Wikibooks, open books for an open world
< Radiation Oncology‎ | RTOG Trials
Jump to: navigation, search


RTOG 03-21 (PROSTATE)

  • Title: Phase II Trial of Combined High Dose Rate Brachytherapy and External Beam Radiotherapy for Adenocarcinoma of the Prostate
  • Objective: To estimate the rate of late Grade 3 or greater genitourinary and gastrointestinal toxicity following treatment with external beam radiation therapy and high dose rate brachytherapy
  • Protocol: 45 Gy EBRT (no IMRT) + 19 Gy (2 fractions) HDR boost
  • Eligibility:
    • (cT1c-T2c and GS 2-6 and PSA 10-20) or
    • (cT3a-T3b and GS 2-6 and PSA <=20) or
    • (T1c-T3b and GS 7-10 and PSA <=20)
    • N0M0
  • Enrollment Target: 110 patients
  • Activation: July 30, 2004